Literature DB >> 28490535

Vaccines to Accelerate Malaria Elimination and Eventual Eradication.

Julie Healer1, Alan F Cowman1, David C Kaslow2, Ashley J Birkett3.   

Abstract

Remarkable progress has been made in coordinated malaria control efforts with substantial reductions in malaria-associated deaths and morbidity achieved through mass administration of drugs and vector control measures including distribution of long-lasting insecticide-impregnated bednets and indoor residual spraying. However, emerging resistance poses a significant threat to the sustainability of these interventions. In this light, the malaria research community has been charged with the development of a highly efficacious vaccine to complement existing malaria elimination measures. As the past 40 years of investment in this goal attests, this is no small feat. The malaria parasite is a highly complex organism, exquisitely adapted for survival under hostile conditions within human and mosquito hosts. Here we review current vaccine strategies to accelerate elimination and the potential for novel and innovative approaches to vaccine design through a better understanding of the host-parasite interaction.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28490535      PMCID: PMC5580511          DOI: 10.1101/cshperspect.a025627

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  110 in total

1.  Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.

Authors:  Edwin Lasonder; Yasushi Ishihama; Jens S Andersen; Adriaan M W Vermunt; Arnab Pain; Robert W Sauerwein; Wijnand M C Eling; Neil Hall; Andrew P Waters; Hendrik G Stunnenberg; Matthias Mann
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

2.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

3.  Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle.

Authors:  Louisa McRobert; Peter Preiser; Sarah Sharp; William Jarra; Mallika Kaviratne; Martin C Taylor; Laurent Renia; Colin J Sutherland
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Authors:  Olivier Silvie; Eric Rubinstein; Jean-François Franetich; Michel Prenant; Elodie Belnoue; Laurent Rénia; Laurent Hannoun; Wijnand Eling; Shoshana Levy; Claude Boucheix; Dominique Mazier
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

5.  Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.

Authors:  K H Rieckmann; R L Beaudoin; J S Cassells; K W Sell
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers.

Authors:  G Lawrence; Q Q Cheng; C Reed; D Taylor; A Stowers; N Cloonan; C Rzepczyk; A Smillie; K Anderson; D Pombo; A Allworth; D Eisen; R Anders; A Saul
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

7.  Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut.

Authors:  Y L Tsai; R E Hayward; R C Langer; D A Fidock; J M Vinetz
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

9.  Genome sequence of the human malaria parasite Plasmodium falciparum.

Authors:  Malcolm J Gardner; Neil Hall; Eula Fung; Owen White; Matthew Berriman; Richard W Hyman; Jane M Carlton; Arnab Pain; Karen E Nelson; Sharen Bowman; Ian T Paulsen; Keith James; Jonathan A Eisen; Kim Rutherford; Steven L Salzberg; Alister Craig; Sue Kyes; Man-Suen Chan; Vishvanath Nene; Shamira J Shallom; Bernard Suh; Jeremy Peterson; Sam Angiuoli; Mihaela Pertea; Jonathan Allen; Jeremy Selengut; Daniel Haft; Michael W Mather; Akhil B Vaidya; David M A Martin; Alan H Fairlamb; Martin J Fraunholz; David S Roos; Stuart A Ralph; Geoffrey I McFadden; Leda M Cummings; G Mani Subramanian; Chris Mungall; J Craig Venter; Daniel J Carucci; Stephen L Hoffman; Chris Newbold; Ronald W Davis; Claire M Fraser; Bart Barrell
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

10.  Discovery of gene function by expression profiling of the malaria parasite life cycle.

Authors:  Karine G Le Roch; Yingyao Zhou; Peter L Blair; Muni Grainger; J Kathleen Moch; J David Haynes; Patricia De La Vega; Anthony A Holder; Serge Batalov; Daniel J Carucci; Elizabeth A Winzeler
Journal:  Science       Date:  2003-07-31       Impact factor: 47.728

View more
  16 in total

Review 1.  Genetic approach towards a vaccine against malaria.

Authors:  Jose Antonio Garrido-Cardenas; Concepción Mesa-Valle; Francisco Manzano-Agugliaro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-28       Impact factor: 3.267

Review 2.  Immune Responses in Malaria.

Authors:  Carole A Long; Fidel Zavala
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

Review 3.  Malaria diagnostic methods with the elimination goal in view.

Authors:  Olukunle O Oyegoke; Leah Maharaj; Oluwasegun P Akoniyon; Illiya Kwoji; Alexandra T Roux; Taiye S Adewumi; Rajendra Maharaj; Bolanle T Oyebola; Matthew A Adeleke; Moses Okpeku
Journal:  Parasitol Res       Date:  2022-04-23       Impact factor: 2.383

4.  Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study.

Authors:  Jason Carnes; William Chad Young; Lindsay Carpp; Daniel E Neafsey; Claudia Daubenberger; M Juliana McElrath; Carlota Dobaño; Ken Stuart; Raphael Gottardo; Gemma Moncunill; Stephen De Rosa; Joseph J Campo; Augusto Nhabomba; Maxmillian Mpina; Chenjerai Jairoce; Greg Finak; Paige Haas; Carl Muriel; Phu Van; Héctor Sanz; Sheetij Dutta; Benjamin Mordmüller; Selidji T Agnandji; Núria Díez-Padrisa; Nana Aba Williams; John J Aponte; Clarissa Valim
Journal:  Elife       Date:  2022-01-21       Impact factor: 8.713

5.  Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.

Authors:  Camila Henriques Coelho; Justin Yai Alamou Doritchamou; Irfan Zaidi; Patrick E Duffy
Journal:  NPJ Vaccines       Date:  2017-11-30       Impact factor: 7.344

6.  Future use-cases of vaccines in malaria control and elimination.

Authors:  Melissa A Penny; Flavia Camponovo; Nakul Chitnis; Thomas A Smith; Marcel Tanner
Journal:  Parasite Epidemiol Control       Date:  2020-05-06

7.  Detection of host pathways universally inhibited after Plasmodium yoelii infection for immune intervention.

Authors:  Lu Xia; Jian Wu; Sittiporn Pattaradilokrat; Keyla Tumas; Xiao He; Yu-Chih Peng; Ruili Huang; Timothy G Myers; Carole A Long; Rongfu Wang; Xin-Zhuan Su
Journal:  Sci Rep       Date:  2018-10-16       Impact factor: 4.379

8.  Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.

Authors:  Catherin Marin-Mogollon; Fiona J A van Pul; Shinya Miyazaki; Takashi Imai; Jai Ramesar; Ahmed M Salman; Beatrice M F Winkel; Ahmad Syibli Othman; Hans Kroeze; Severine Chevalley-Maurel; Arturo Reyes-Sandoval; Meta Roestenberg; Blandine Franke-Fayard; Chris J Janse; Shahid M Khan
Journal:  Malar J       Date:  2018-08-09       Impact factor: 2.979

9.  Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.

Authors:  Itziar Ubillos; Aintzane Ayestaran; Augusto J Nhabomba; David Dosoo; Marta Vidal; Alfons Jiménez; Chenjerai Jairoce; Hèctor Sanz; Ruth Aguilar; Nana Aba Williams; Núria Díez-Padrisa; Maximilian Mpina; Hermann Sorgho; Selidji Todagbe Agnandji; Simon Kariuki; Benjamin Mordmüller; Claudia Daubenberger; Kwaku Poku Asante; Seth Owusu-Agyei; Jahit Sacarlal; Pedro Aide; John J Aponte; Sheetij Dutta; Ben Gyan; Joseph J Campo; Clarissa Valim; Gemma Moncunill; Carlota Dobaño
Journal:  BMC Med       Date:  2018-10-31       Impact factor: 8.775

10.  Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination.

Authors:  Theodora U J Bruun; Anne-Marie C Andersson; Simon J Draper; Mark Howarth
Journal:  ACS Nano       Date:  2018-07-26       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.